STOCK TITAN
  1. Home
  2. Financials
  3. ARCT
  4. EPS (Diluted)

Arcturus Therapeutics Holdings Inc. (ARCT) EPS by Year

ARCT

Arcturus Therapeutics Holdings Inc. lost $2.40 per diluted share in fiscal year 2025. This represents an increase of 20.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $3.33 per diluted share. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Arcturus Therapeutics Holdings Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$2.40
YoY +20.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ARCT EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
EPS (Diluted)-$3.33-$2.40+20.0%-$3.00-167.9%-$1.12-420.0%$0.35+104.5%-$7.74N/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ARCT EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.84-147.1%-$0.95-82.7%-$1.05+5.4%-$0.49-88.5%-$0.34+46.9%-$0.52+48.0%-$1.11-152.3%-$0.26+57.4%-$0.64+67.7%-$1.00-153.5%-$0.44-109.9%-$0.61+54.1%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Arcturus Therapeutics Holdings Inc. financials

Frequently Asked Questions

What was Arcturus Therapeutics Holdings Inc.'s diluted earnings per share in fiscal year 2025?

Arcturus Therapeutics Holdings Inc. lost $2.40 per diluted share in fiscal year 2025.

How fast is Arcturus Therapeutics Holdings Inc.'s diluted earnings per share growing?

Arcturus Therapeutics Holdings Inc. (ARCT) diluted earnings per share rose by 20.0% year over year, from -$3.00 to -$2.40 in fiscal year 2025.

What is Arcturus Therapeutics Holdings Inc.'s diluted earnings per share over the last twelve months?

Arcturus Therapeutics Holdings Inc. (ARCT) reported a loss of $3.33 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Arcturus Therapeutics Holdings Inc. (ARCT) reported -$0.84 in diluted earnings per share in Q2 2026. This represents a decrease of 147.1% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Arcturus Therapeutics Holdings Inc. (ARCT) reported on that line in every period on record.